Cervical Cancer News

FDA Approves Merck’s Keytruda® for Previously Treated Patients with Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (June 18, 2018)

The U.S. Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy whose tumors express PD-L1.  Keytruda is the... Continue Reading

Questions to Ask Before Radiation Therapy for the Treatment of Cervical Cancer (December 13, 2017)

Radiation therapy, or radiotherapy, is a common way to treat cervical cancer. Doctors who specialize in treating cancers with radiation are known as radiation oncologists. During radiation therapy, high-energy x-rays are used to kill cancer cells. Radiation... Continue Reading

Managment of the Side Effects of Radiation for Cervical Cancer (December 7, 2017)

Radiation therapy, or radiotherapy, is a common way to treat cervical cancer. With any treatment of cancer you must first understand your responsibility and your medical team’s role as well as explore treatment options and get a second opinion(s) before... Continue Reading

What You Should Know About the Side Effects of Surgery for Cervical Cancer (December 6, 2017)

A hysterectomy is a common surgical treatment of early stage cancer and precancerous disease of the cervix in women. With any treatment of cancer it is important to first understand your responsibility and your medical team’s role as well as explore... Continue Reading

Cervical Cancer Survivors Frequently Suffer From Long-Term Side Effects of Treatment (August 17, 2017)

According to a new study around half of women who have been treated for locally advanced cervical cancer suffer from symptoms of insomnia, fatigue or hot flushes.1 Cervical cancer affects more than 500,000 women around the world each year with an average... Continue Reading

Genmab Announces Preliminary Cervical Cancer Data from Tisotumab Vedotin Phase I/II Study (July 5, 2017)

Data from an ongoing clinical study of tisotumab vedotin in solid tumors has demonstrated activity in the treatment of cervical cancer; 11 of 34 evaluable patients achieved a response; with a median time of treatment of 4.9 months and 7 responders are... Continue Reading

Immune Therapy Produces Anti-Cancer Responses in Advanced Cervical Cancer (April 24, 2017)

Adoptive T-cell therapy (ACT) appears to provide anti-cancer responses among patients with advanced cervical cancer for whom standard therapy has stopped working. These results were published in the Journal of Clinical Oncology. The most common cause... Continue Reading

Nearly half of U.S. men actively infected with HPV, study finds HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated! (February 20, 2017)

By Rachel Tompa / Fred Hutch News Service The most common sexually transmitted infection in the U.S. has a bit of a twist. It’s what’s known as a “subclinical infection” — those infected suffer no immediate consequences, but years later have... Continue Reading

The HPV Vaccine Prevents Lesions That Could Cause Cervical Cancer by 50 Percent (October 13, 2016)

A recent report published online Sept. 29 in the journal JAMA Oncology suggests that the vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, is more effective than previously thought. Human... Continue Reading

HPV Testing Found to Be More Effective Than Pap Smears in Evaluating Cervical Cancer Risk (July 23, 2014)

Researchers at the National Cancer Institute reported that testing for HPV (human papillomavirus) is the most effective way to determine whether a woman is at risk for developing cervical cancer in the near future. Specifically, the study found that negative... Continue Reading

Latest Cervical Cancer News By Stage


Metastatic/Stage IVB Cervical Cancer

January Is National Cervical Cancer Awareness Month (January 5, 2010)

As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer... Continue Reading

More Metastatic/Stage IVB Cervical Cancer

Recurrent Cervical Cancer

January Is National Cervical Cancer Awareness Month (January 5, 2010)

As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer... Continue Reading

More Recurrent Cervical Cancer

Screening/Prevention Cervical Cancer

The HPV Vaccine Prevents Lesions That Could Cause Cervical Cancer by 50 Percent (October 13, 2016)

A recent report published online Sept. 29 in the journal JAMA Oncology suggests that the vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, is more effective than previously thought. Human... Continue Reading

HPV Testing Found to Be More Effective Than Pap Smears in Evaluating Cervical Cancer Risk (July 23, 2014)

Researchers at the National Cancer Institute reported that testing for HPV (human papillomavirus) is the most effective way to determine whether a woman is at risk for developing cervical cancer in the near future. Specifically, the study found that negative... Continue Reading

Gardasil Provides Poor Protection in Women Over 18 (February 3, 2014)

A significant percentage of women vaccinated with Gardasil® (quadrivalent human papillomavirus recombinant vaccine) may not be protected against high-grade squamous intraepithelial lesions (HSIL) and lesser dysplasia—especially if they were vaccinated... Continue Reading

HPV Vaccine Protects Against Genital Warts and Precancerous Growths (July 30, 2010)

Results from a recent international study indicate that the vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) protects against genital warts and low-grade precancerous changes to the cervix, vulva, and vagina.... Continue Reading

Many Physicians Fail to Adhere to New Cervical Cancer Screening Guidelines (July 12, 2010)

Apparently, old habits die hard: less than one-third of physicians report compliance with the updated guidelines for cervical cancer screening that suggest longer intervals between screening for women with normal test results. The results of this survey... Continue Reading

More Screening/Prevention Cervical Cancer

Stages II-IVA Cervical Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading

January Is National Cervical Cancer Awareness Month (January 5, 2010)

As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer... Continue Reading

More Stages II-IVA Cervical Cancer